Evox is engineering exosomes—lipid-membrane-containing nanoparticles constitutively produced by cells—and loading them with protein therapeutics or nucleic-acid-based agents (Fig. 1).

Evox Therapeutics is the second UK biotech to ... near-term milestones and research funding – is focusing on the development of protein replacement and mRNA therapies that will be delivered ...